K2 Principal Fund, L.P. Genfit S.A. Transaction History

K2 Principal Fund, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.53 - $6.06 $203,025 - $271,597	-44,818 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.63 - $5.6 $117,150 - $180,728	32,273 Added 257.26%	44,818 $215,000
Q3 2020 Nov 13, 2020	BUY	$3.67 - $5.59 $46,040 - $70,126	12,545 New	12,545 $66,000

49.2K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $293M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.